Denise M. Boudreau - Publications

Affiliations: 
Epidemiology University of Washington, Seattle, Seattle, WA 
Area:
Epidemiology, Oncology

57 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zhou J, Asfaw AA, Nabulsi NA, Mukand NA, Lee I, Ko NY, Boudreau DM, Calip GS. HSR20-113: Diabetes Complications and Risks of Breast Cancer Recurrence Among Older Women Journal of the National Comprehensive Cancer Network. 18: HSR20-113. DOI: 10.6004/Jnccn.2019.7475  0.64
2019 Gold HT, Shao H, Oratz R, Yu O, Hammer M, Richardson S, Boudreau D. Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer. American Journal of Clinical Oncology. PMID 31850918 DOI: 10.1097/COC.0000000000000638  0.382
2019 Calip GS, Yu O, Boudreau DM, Shao H, Oratz R, Richardson SB, Gold HT. Diabetes and differences in detection of incident invasive breast cancer. Cancer Causes & Control : Ccc. PMID 30949885 DOI: 10.1007/S10552-019-01166-2  0.622
2019 Boudreau DM, Chen L, Yu O, Bowles EJA, Chubak J. Risk of second breast cancer events with chronic opioid use in breast cancer survivors. Pharmacoepidemiology and Drug Safety. PMID 30945381 DOI: 10.1002/pds.4779  0.37
2019 Bowles EJA, Yu O, Ziebell R, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Boggs JM, Burnett-Hartman AN, Sterrett A, Fujii M, Chubak J. Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study. Bmc Cancer. 19: 270. PMID 30917783 DOI: 10.1186/S12885-019-5493-8  0.338
2019 Pocobelli G, Yu O, Ziebell RA, Aiello Bowles EJ, Fujii MM, Sterrett AT, Boggs JM, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Chubak J. Use of antidepressants after colon cancer diagnosis and risk of recurrence. Psycho-Oncology. PMID 30703275 DOI: 10.1002/Pon.5015  0.307
2018 Salz T, Lavery JA, Lipitz Snyderman AN, Boudreau D, Moryl N, Gillespie EF, Korenstein D. Trends in chronic opioid therapy among cancer survivors. Journal of Clinical Oncology. 36: 6584-6584. DOI: 10.1200/Jco.2018.36.15_Suppl.6584  0.403
2017 Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Diabetes treatments and risks of adverse breast cancer outcomes among early stage breast cancer patients: A SEER-Medicare analysis. Cancer Research. PMID 28935814 DOI: 10.1158/0008-5472.CAN-17-0687  0.43
2017 Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-Medicare population. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28807926 DOI: 10.1158/1055-9965.EPI-17-0346  0.402
2017 Boudreau DM, Yu O, Balasubramanian A, Wirtz H, Grauer A, Crittenden DB, Scholes D. A Survey of Women's Awareness of and Reasons for Lack of Postfracture Osteoporotic Care. Journal of the American Geriatrics Society. PMID 28422273 DOI: 10.1111/Jgs.14921  0.673
2017 Wirtz HS, Calip GS, Buist DS, Gralow JR, Barlow WE, Gray S, Boudreau DM. Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors. American Journal of Epidemiology. 1-12. PMID 28338879 DOI: 10.1093/Aje/Kww242  0.785
2017 Raebel MA, Zeng C, Cheetham TC, Smith DH, Feigelson HS, Carroll NM, Goddard K, Tavel HM, Boudreau DM, Shetterly S, Xu S. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women. American Journal of Epidemiology. 185: 264-273. PMID 28186527 DOI: 10.1093/Aje/Kww217  0.513
2017 Chen L, Chubak J, Boudreau D, Barlow W, Weiss N, Li C. Diabetes Treatment and Risks of Adverse Breast Cancer Outcomes Among Elderly Breast Cancer Patients: A SEER-Medicare Analysis Journal of Patient-Centered Research and Reviews. 4: 148. DOI: 10.17294/2330-0698.1468  0.483
2016 Calip GS, Elmore JG, Boudreau DM. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors. Breast Cancer Research and Treatment. PMID 27826756 DOI: 10.1007/S10549-016-4043-1  0.658
2016 Drieling RL, LaCroix AZ, Beresford SA, Boudreau DM, Kooperberg C, Chlebowski RT, Gass M, Crandall CJ, Womack CR, Heckbert SR. Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative. Menopause (New York, N.Y.). PMID 27433859 DOI: 10.1097/Gme.0000000000000696  0.444
2016 Drieling RL, LaCroix AZ, Beresford SA, Boudreau DM, Kooperberg C, Heckbert SR. Validity of Self-Reported Medication Use Compared With Pharmacy Records in a Cohort of Older Women: Findings From the Women's Health Initiative. American Journal of Epidemiology. PMID 27402774 DOI: 10.1093/Aje/Kwv446  0.349
2016 Calip GS, Yu O, Elmore JG, Boudreau DM. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study. Cancer Causes & Control : Ccc. PMID 27053250 DOI: 10.1007/S10552-016-0744-3  0.66
2016 Heath LM, Gray SL, Boudreau D, Edwards KL, Fullerton SM, Thummel K, Larson EB. DT-01-03: Common Antidepressant Medications and Risk of Dementia: a Prospective Cohort Study Alzheimer's & Dementia. 12: P1135-P1135. DOI: 10.1016/J.Jalz.2016.07.009  0.333
2015 Chubak J, Bowles EJ, Yu O, Buist DS, Fujii M, Boudreau DM. Breast cancer recurrence in relation to antidepressant use. Cancer Causes & Control : Ccc. PMID 26518198 DOI: 10.1007/S10552-015-0689-Y  0.504
2015 Calip GS, Yu O, Hoskins KF, Boudreau DM. Associations between diabetes medication use and risk of second breast cancer events and mortality. Cancer Causes & Control : Ccc. 26: 1065-77. PMID 25956271 DOI: 10.1007/S10552-015-0599-Z  0.637
2015 Calip GS, Hubbard RA, Stergachis A, Malone KE, Gralow JR, Boudreau DM. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment. Pharmacoepidemiology and Drug Safety. 24: 75-85. PMID 24923811 DOI: 10.1002/Pds.3660  0.631
2015 Calip GS, Boudreau DM. Abstract PD4-6: Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemias among breast cancer survivors Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Pd4-6  0.651
2014 Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM. Metabolic syndrome and outcomes following early-stage breast cancer. Breast Cancer Research and Treatment. 148: 363-77. PMID 25301086 DOI: 10.1007/S10549-014-3157-6  0.634
2014 Wu JW, Boudreau DM, Park Y, Simonds NI, Freedman AN. Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature. Expert Opinion On Drug Safety. 13: 1071-99. PMID 24999107 DOI: 10.1517/14740338.2014.926887  0.425
2014 Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Research and Treatment. 144: 405-16. PMID 24557337 DOI: 10.1007/S10549-014-2870-5  0.774
2014 Roth JA, Boudreau D, Fujii MM, Farin FM, Rettie AE, Thummel KE, Veenstra DL. Genetic risk factors for major bleeding in patients treated with warfarin in a community setting. Clinical Pharmacology and Therapeutics. 95: 636-43. PMID 24503627 DOI: 10.1038/Clpt.2014.26  0.329
2014 Wirtz HS, Boudreau DM, Gralow JR, Barlow WE, Gray S, Bowles EJ, Buist DS. Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors. Breast Cancer Research and Treatment. 143: 541-50. PMID 24407530 DOI: 10.1007/S10549-013-2816-3  0.758
2013 Chubak J, Boudreau DM, Wirtz HS, McKnight B, Weiss NS. Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. Journal of the National Cancer Institute. 105: 1456-62. PMID 23940288 DOI: 10.1093/Jnci/Djt211  0.714
2013 Wirtz HS, Buist DS, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJ, Fujii M, Boudreau DM. Frequent antibiotic use and second breast cancer events. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1588-99. PMID 23833124 DOI: 10.1158/1055-9965.Epi-13-0454  0.765
2013 Chubak J, Yu O, Buist DS, Wirtz HS, Boudreau DM. Time scale in follow-up studies: considering disease prognosis. Epidemiology (Cambridge, Mass.). 24: 628-9. PMID 23732747 DOI: 10.1097/Ede.0B013E3182961708  0.721
2013 Spangler L, Yu O, Loggers E, Boudreau DM. Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors. Journal of Women's Health (2002). 22: 132-40. PMID 23362883 DOI: 10.1089/Jwh.2012.3687  0.394
2013 Calip GS, Boudreau DM, Loggers ET. Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Research and Treatment. 138: 225-33. PMID 23358904 DOI: 10.1007/S10549-013-2424-2  0.657
2013 Boudreau DM, Wirtz H, Von Korff M, Catz SL, St John J, Stang PE. A survey of adult awareness and use of medicine containing acetaminophen. Pharmacoepidemiology and Drug Safety. 22: 229-40. PMID 22890688 DOI: 10.1002/Pds.3335  0.672
2012 Aiello Bowles EJ, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS. Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. Journal of Oncology Practice / American Society of Clinical Oncology. 8: e149-57. PMID 23598850 DOI: 10.1200/Jop.2012.000543  0.4
2012 Bowles EJ, Buist DS, Chubak J, Yu O, Johnson J, Chestnut J, Boudreau DM. Endocrine therapy initiation from 2001 to 2008 varies by age at breast cancer diagnosis and tumor size. Journal of Oncology Practice / American Society of Clinical Oncology. 8: 113-20. PMID 23077439 DOI: 10.1200/Jop.2011.000417  0.448
2011 Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, et al. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. Jama. 306: 2673-83. PMID 22161946 DOI: 10.1001/Jama.2011.1830  0.351
2011 Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use. International Journal of Cancer. Journal International Du Cancer. 128: 227-32. PMID 20232382 DOI: 10.1002/Ijc.25322  0.429
2010 Chubak J, Boudreau DM, Fishman PA, Elmore JG. Cost of breast-related care in the year following false positive screening mammograms. Medical Care. 48: 815-20. PMID 20706161 DOI: 10.1097/Mlr.0B013E3181E57918  0.354
2010 Boudreau DM, Yu O, Johnson J. Statin use and cancer risk: a comprehensive review. Expert Opinion On Drug Safety. 9: 603-21. PMID 20377474 DOI: 10.1517/14740331003662620  0.358
2010 Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD. Cardiovascular events associated with ipratropium bromide in COPD. Chest. 137: 13-9. PMID 19363211 DOI: 10.1378/Chest.08-2367  0.305
2009 Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiology and Drug Safety. 18: 1166-75. PMID 19718704 DOI: 10.1002/Pds.1833  0.302
2009 Weisner CM, Campbell CI, Ray GT, Saunders K, Merrill JO, Banta-Green C, Sullivan MD, Silverberg MJ, Mertens JR, Boudreau D, Von Korff M. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 145: 287-93. PMID 19581051 DOI: 10.1016/J.Pain.2009.05.006  0.335
2009 Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiology and Drug Safety. 18: 540-4. PMID 19367565 DOI: 10.1002/Pds.1749  0.368
2009 Yu O, Boudreau DM, Buist DS, Miglioretti DL. Statin use and female reproductive organ cancer risk in a large population-based setting. Cancer Causes & Control : Ccc. 20: 609-16. PMID 19043788 DOI: 10.1007/S10552-008-9271-1  0.425
2008 Boudreau DM, Koehler E, Rulyak SJ, Haneuse S, Harrison R, Mandelson MT. Cardiovascular medication use and risk for colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3076-80. PMID 18957524 DOI: 10.1158/1055-9965.Epi-08-0095  0.403
2008 Bonomi AE, Boudreau DM, Fishman PA, Ludman E, Mohelnitzky A, Cannon EA, Seger D. Quality of life valuations of mammography screening. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 17: 801-14. PMID 18491217 DOI: 10.1007/S11136-008-9353-2  0.334
2008 Boudreau DM, Yu O, Buist DS, Miglioretti DL. Statin use and prostate cancer risk in a large population-based setting. Cancer Causes & Control : Ccc. 19: 767-74. PMID 18322813 DOI: 10.1007/S10552-008-9139-4  0.379
2008 Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Research and Treatment. 112: 123-32. PMID 18058227 DOI: 10.1007/S10549-007-9828-9  0.488
2008 Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R. Use of antidepressant medications during pregnancy: a multisite study. American Journal of Obstetrics and Gynecology. 198: 194.e1-5. PMID 17905176 DOI: 10.1016/J.Ajog.2007.07.036  0.326
2007 Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR. Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 416-21. PMID 17372235 DOI: 10.1158/1055-9965.Epi-06-0737  0.484
2006 Boudreau DM, Rutter CM, Buist DS. The influence of statin use on breast density. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1026-9. PMID 16702387 DOI: 10.1158/1055-9965.Epi-05-0802  0.392
2006 Boudreau DM, Buist DS, Rutter CM, Fishman PA, Beverly KR, Taplin S. Impact of hormone therapy on false-positive recall and costs among women undergoing screening mammography. Medical Care. 44: 62-9. PMID 16365614 DOI: 10.1097/01.Mlr.0000188969.83608.92  0.307
2006 Chien C, Li CI, Heckbert SR, Malone KE, Boudreau DM, Daling JR. Antidepressant use and breast cancer risk. Breast Cancer Research and Treatment. 95: 131-40. PMID 16322894 DOI: 10.1007/S10549-005-9056-0  0.489
2006 Boudreau D, Yu O, Miglioretti D, Buist D. Statins and Breast Cancer Risk: Is There an Association? American Journal of Epidemiology. 163: S256-S256. DOI: 10.1093/Aje/163.Suppl_11.S256-B  0.482
2004 Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK, Daling JR. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study. Cancer. 100: 2308-16. PMID 15160333 DOI: 10.1002/Cncr.20271  0.443
2004 Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, Heckbert SR. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. American Journal of Epidemiology. 159: 308-17. PMID 14742292 DOI: 10.1093/Aje/Kwh038  0.353
2003 Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer. 98: 1504-13. PMID 14508839 DOI: 10.1002/Cncr.11663  0.419
Show low-probability matches.